Skip to main content
Practice Management
BEACOPP Regimen Superior to ABVD in Newly Diagnosed, Advanced Hodgkin Lymphoma
Chase Doyle
Read More
Leukemia, Oncology
American Society of Hematology 2016: Leukemia Highlights
Read More
Practice Management
Increased Utilization of Biosimilars in Oncology Could Save Payers Millions
Chase Doyle
Read More
Practice Management
Value Frameworks Unreliable in Assessing Novel Hematologic Therapies
Chase Doyle
Read More
Practice Management
Frontline Use of Bendamustine plus Rituximab Cost-Effective for Indolent B-Cell Non-Hodgkin Lymphoma
Chase Doyle
Read More
Practice Management
ASCO Value Framework Ill-Equipped to Assess Value of Therapies in Chronic Lymphocytic Leukemia
Chase Doyle
Read More
Multiple Myeloma, Oncology
American Society of Hematology 2016: Multiple Myeloma Highlights
Read More
Leukemia, Oncology
Lenalidomide Maintenance Therapy Extends Progression-Free Survival in Patients with High-Risk Chronic Lymphocytic Leukemia
Wayne Kuznar
Read More
Leukemia, Oncology
Ponatinib, a Tyrosine Kinase Inhibitor, Active in Patients with Relapsed or Refractory Chronic Myeloid Leukemia and BCR-ABL T315I Mutation
Charles Bankhead
Read More
Leukemia, Oncology
CPX-351 Improves Posttransplant Survival in Older Patients with High-Risk Acute Myeloid Leukemia
Phoebe Starr
Read More
Page 1 of 3
Results 1 - 10 of 27